Login / Signup

Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients.

Camilla de Almeida MartinsMatheus Freitas Cardoso de AzevedoAlexandre Sousa CarlosAderson Omar Mourão Cintra DamiãoCarlos Walter Sobrado JuniorSergio Carlos NahasNatália Souza Freitas Queiroz
Published in: Therapeutic advances in gastroenterology (2023)
4.254.501 and 2.903.748.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • stem cells
  • patient reported
  • smoking cessation